Article | September 05, 2024
Navigating the Biosecure Act: Implications for Biotechnology and Pharmaceutical Companies
Read More
Article | August 27, 2024
Kickbacks and Consequences: Lessons from the Innovasis Settlement
Read More
Article | August 14, 2024
FDA Faces Pressure to Enhance Oversight of Online Prescription Drug Promotions
Read More
Article | August 01, 2024
FDA Unveils Criteria for Reporting Real-World Evidence (RWE) Submissions
Read More
Article | July 10, 2024
Privacy Summer School: 10 Things You Should Know About Privacy, Consent, and HIPAA
Read More
Article | June 27, 2024
Expert Insights from In-House Lawyers: Navigating Legal and Regulatory Challenges
Read More
Article | June 13, 2024
FDA Publishes Final Rule Related to the Regulation of Food Contact Notifications
Read More
Article | June 12, 2024
Navigating HIPAA and State Privacy Laws for Drug and Device Manufacturers
Read More
Article | May 30, 2024
FDA Publishes Paper Identifying Focus Areas for “Responsible Use of AI” in Medical Products
Read More
Article | May 20, 2024
Chevron Challenges: Supreme Court Decisions Could Reshape FDA Authority
Read More
Article | May 16, 2024